↓ Skip to main content

Febuxostat for treating chronic gout

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Febuxostat for treating chronic gout
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008653.pub2
Pubmed ID
Authors

Jean H Tayar, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor

Abstract

Gout is the most common inflammatory arthritis in men over 40 years and has an increasing prevalence among postmenopausal women. Lowering serum uric acid levels remains one of the primary goals in the treatment of chronic gout. In clinical trials, febuxostat has been shown to be effective in lowering serum uric acid levels to < 6.0 mg/dL.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 2%
Denmark 1 <1%
Italy 1 <1%
United Kingdom 1 <1%
Unknown 108 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 21%
Student > Bachelor 24 21%
Researcher 14 12%
Student > Ph. D. Student 12 11%
Student > Postgraduate 9 8%
Other 11 10%
Unknown 19 17%
Readers by discipline Count As %
Medicine and Dentistry 49 43%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Social Sciences 5 4%
Psychology 4 4%
Other 14 12%
Unknown 25 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2020.
All research outputs
#1,241,816
of 15,692,207 outputs
Outputs from Cochrane database of systematic reviews
#3,341
of 11,258 outputs
Outputs of similar age
#18,637
of 258,439 outputs
Outputs of similar age from Cochrane database of systematic reviews
#182
of 500 outputs
Altmetric has tracked 15,692,207 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,258 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.3. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 500 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.